Clinical Trial Update: Interest of Intrathecal Chemotherapy With Liposomal Cytarabine (DepoCyte®) in Meningeal Metastasis of Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating intrathecal liposomal cytarabine (DepoCyte) for leptomeningeal metastases from breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Leptomeningeal Metastases

Drugs mentioned

• Liposomal cytarabine (cytarabine liposome)

Snippet

Sponsor: Centre Oscar Lambret | Conditions: Breast Cancer, Leptomeningeal Metastases | Phase 3 | Status: COMPLETED